Pancreatic Cancer Research

ResearcherGarvan Institute of Medical ResearchNo recent work listed

Jeremy L. Humphris

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5078018412. Sources: OpenAlex.

Their work

Papers
15
Trials
0
Grants
0
Labs led
0
Collaborators
37
Papers, trials and grants by year

2012: 2 papers · 2013: 1 paper · 2014: 3 papers · 2015: 3 papers · 2016: 2 papers · 2017: 1 paper · 2018: none · 2019: none · 2020: 2 papers · 2021: 1 paper

Papers 15

  1. Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2020.09.043↗
  2. HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer. Co-author DOI 10.1016/j.celrep.2020.107625↗
  3. Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000003143↗
  4. Hypermutation In Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2016.09.060↗
  5. Diagnosis and Management of Hereditary Pancreatic Cancer. Co-author DOI 10.1007/978-3-319-29998-3_5↗
  6. Genomic analyses identify molecular subtypes of pancreatic cancer. Co-author DOI 10.1038/nature16965↗
  7. Whole genomes redefine the mutational landscape of pancreatic cancer. Co-author DOI 10.1038/nature14169↗
  8. Inherited susceptibility to pancreatic cancer in the era of next-generation sequencing. Co-author DOI 10.1053/j.gastro.2015.01.009↗
  9. Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial. Co-author DOI 10.1158/1078-0432.ccr-15-0426↗
  10. Clinical and pathologic features of familial pancreatic cancer. Co-author DOI 10.1002/cncr.28863↗
  11. Adjuvant chemotherapy in elderly patients with pancreatic cancer. Co-author DOI 10.1038/bjc.2013.722↗
  12. Returning individual research results for genome sequences of pancreatic cancer. Co-author DOI 10.1186/gm558↗
  13. Clinical and molecular characterization of HER2 amplified-pancreatic cancer. Co-author DOI 10.1186/gm482↗
  14. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Co-author DOI 10.1038/nature11547↗
  15. The prognostic and predictive value of serum CA19.9 in pancreatic cancer. Co-author DOI 10.1093/annonc/mdr561↗

Closest collaborators

The 25 strongest of 37 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andrew Victor Biankin · 9 shared papers, 2012–2020 · strength 0.46
  2. David Kuang-Fu Chang · 8 shared papers, 2012–2020 · strength 0.34
  3. Jaswinder Singh Samra · 7 shared papers, 2012–2020 · strength 0.25
  4. Amber L. Johns · 7 shared papers, 2012–2020 · strength 0.25
  5. Marina Pajic · 7 shared papers, 2012–2020 · strength 0.25
  6. Anthony James Gill · 7 shared papers, 2012–2020 · strength 0.25
  7. Venessa T. Chin · 6 shared papers, 2012–2020 · strength 0.22
  8. Lorraine A. Chantrill · 6 shared papers, 2012–2020 · strength 0.22
  9. Adnan M. Nagrial · 6 shared papers, 2012–2020 · strength 0.22
  10. Angela S. Y. Chou · 4 shared papers, 2013–2020 · strength 0.16
  11. James G. Kench · 4 shared papers, 2012–2020 · strength 0.16
  12. Christopher James Scarlett · 3 shared papers, 2012–2020 · strength 0.13
  13. Emily K. Colvin · 3 shared papers, 2012–2020 · strength 0.13
  14. Mark J. Cowley · 3 shared papers, 2013–2020 · strength 0.13
  15. Sean Michael Grimmond · 4 shared papers, 2013–2015 · strength 0.13
  16. Neil Donald Merrett · 2 shared papers, 2012–2020 · strength 0.10
  17. Stephan B. Dreyer · 1 shared paper, 2020 · strength 0.07
  18. Peter J. Bailey · 1 shared paper, 2020 · strength 0.07
  19. Nam Quoc Nguyen · 1 shared paper, 2020 · strength 0.07
  20. Thomas Knösel · 1 shared paper, 2020 · strength 0.07
  21. Nigel Balfour Jamieson · 1 shared paper, 2020 · strength 0.07
  22. Colin J. McKay · 1 shared paper, 2020 · strength 0.07
  23. C. Ross Carter · 1 shared paper, 2020 · strength 0.07
  24. Robert Grützmann · 1 shared paper, 2020 · strength 0.07
  25. Christian P. Pilarsky · 1 shared paper, 2020 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.